CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Dual Antiplatelet TherapyIs It Time to Cut the Cord With Aspirin? Haemodynamic definitions and updated clinical classification of pulmonary hypertension Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry Procedural Success and Outcomes With Increasing Use of Enabling Strategies for Chronic Total Occlusion Intervention AIM2-driven inflammasome activation in heart failure Current treatment of significant left main coronary artery disease: A review Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced

Original Research2020 Jun 7;128:110336.

JOURNAL:Biomed Pharmacother. Article Link

Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention

YN Dai, JL Huang, DQ Yu et al. Keywords: atorvastatin; rosuvastatin; STEMI; PCI; post-contrast acute kidney injury

Full Text PDF